Track Venus Concept Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Venus Concept Inc. VERO Open Venus Concept Inc. in new tab

0.3110 USD
EPS
-45.26
P/B
0.22
ROE
-794.55
Beta
-0.06
Venus Concept Inc. logo

Venus Concept Inc.

🧾 Earnings Recap – Q3 2025

Venus Concept Inc. reported a high single-digit year-over-year decline in total revenue for Q3 2025, primarily due to softness in the hair restoration segment, although sales of energy-based devices showed 2% growth.

  • Strong execution led to a 2% increase in sales of energy-based devices, particularly in key US markets.
  • The launch of the Venus Nova platform, designed to enhance non-invasive treatments, reflects the company's strategic R&D focus and targets significant market segments responding to GLP-1 medication trends.
  • Challenges with the pending sale of the Venus Hair business are ongoing, including delays due to counterparty issues and legal assistance sought for resolution.
  • Financial restructuring efforts included a $11.5 million debt-to-equity exchange, improving liquidity as the company prepares for future growth initiatives.
  • Anticipated sequential revenue growth in Q4 2025 supported by the limited commercial launch of Venus Nova in December.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateMay 13, 2026
EPS-45.26
Book Value1.44
Price to Book0.22
Debt/Equity1042.31
% Insiders0.821%
Growth
Revenue Growth-0.08%
Estimates
Forward P/E-0.14
Forward EPS-2.27

DCF Valuation

Tweak assumptions to recompute fair value for Venus Concept Inc. (VERO)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Venus Concept Inc. Logo Venus Concept Inc. Analysis (VERO)

Canada Health Care Official Website Stock

Is Venus Concept Inc. a good investment? Venus Concept Inc. (VERO) is currently trading at 0.3110 USD.

Earnings Schedule: Venus Concept Inc. is expected to release its next earnings report on May 13, 2026. The market consensus estimate for Forward EPS is -2.27.

Investor FAQ

Does Venus Concept Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Venus Concept Inc.?

Venus Concept Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be May 13, 2026. The company currently has a trailing EPS of -45.26.

Company Profile

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Exchange Ticker
NGM (Sweden) VERO

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
March 4, 2025 0.090000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
May 12, 2023 0.070000
Nov. 8, 2019 0.070000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion